DEFINITIVE PROXY STATEMENT

Company

ENDRA Life Sciences Inc.

Filed

April 15, 2019

Period of Report

May 16, 2019

Accession Number

0001213900-19-006402

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →